Genaissance Pharmaceuticals Joins MSI s Functional Genomics Consortium | GenomeWeb

NEW YORK, Feb 16 – Genaissance Pharmaceuticals has joined the Molecular Simulations’ Functional Genomics consortium, MSI said Friday.

Membership in this consortium gives Genaissance access to MSIs AtlasBase collection of functionally annoted gene sequences from 23 organisms and software that allows it to search this database, said Sue Rodney, manager of investor relations at Pharmacopeia, MSI’s parent company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.